- Home
- KULR vs INO Comparison
KULR vs INO Comparison
Compare KULR & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KULR | INO |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.8M | 114.0M |
| IPO Year | 2016 | 1999 |
Fundamental Metrics
Financial Performance| Metric | KULR | INO |
|---|---|---|
| Price | $2.10 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | $1,274,028.00 | ★ $42,220,086.00 |
| Revenue This Year | $64.40 | $24,407.60 |
| Revenue Next Year | $105.13 | $331.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $0.73 | $1.07 |
| 52 Week High | $7.49 | $2.86 |
Technical Indicators
Market Signals| Indicator | KULR | INO |
|---|---|---|
| Relative Strength Index (RSI) | 34.03 | 26.12 |
| Support Level | $0.73 | N/A |
| Resistance Level | $3.16 | $1.56 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 18.68 | 9.03 |
Price Performance
Historical ComparisonAbout KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.